Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
15.45
+0.04 (0.26%)
Apr 28, 2025, 11:00 AM EDT - Market open
Neurogene Employees
Neurogene had 107 employees as of December 31, 2024. The number of employees increased by 16 or 17.58% compared to the previous year.
Employees
107
Change (1Y)
16
Growth (1Y)
17.58%
Revenue / Employee
$8,645
Profits / Employee
-$702,280
Market Cap
220.35M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 107 | 16 | 17.58% |
Dec 31, 2023 | 91 | 9 | 10.98% |
Dec 31, 2022 | 82 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
NGNE News
- 25 days ago - Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome - Business Wire
- 4 weeks ago - Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates - Business Wire
- 2 months ago - Neurogene to Participate in Upcoming Conferences - Business Wire
- 5 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neurogene Inc. (NGNE) And Encourages Shareholders to Reach Out - Accesswire
- 5 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Neurogene Inc. (NGNE) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 5 months ago - Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 5 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages Neurogene Inc. (NGNE) Shareholders to Inquire about Securities Investigation - Accesswire
- 5 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Neurogene Inc. (NGNE) And Encourages Investors to Connect - Accesswire